Association studies between gene variants (polymorphisms) and measured intermediate phenotypes (such as lipid/lipoprotein levels), or disease phenotypes (such as ischaemic heart disease (IHD)) are increasingly common in the literature. Indeed, there is mounting evidence that classical risk factors for IHD, such as hypertension, diabetes mellitus and hyperlipidaemia, are polygenic traits, and their interaction with environment factors (such as diet, lifestyle, occupational, socioeconomic factors, etc.) are important in determining their phenotypic expression.
A gene-environment interaction denotes the notion that different genotypes respond differently to exposure to similar environmental risk factors; thus, genes that do not affect the mean expression of a trait may increase susceptibility to disease during adverse environmental influences. Indeed, it is probable that different populations and groups within populations have genetically determined differences in susceptibility to environmental influences. For example, the increased risk of IHD and Type 2 diabetes mellitus in Southeast Asian Indians who have migrated to the United Kingdom has been attributed to their increased susceptibility to abdominal fat, dyslipidaemia and insulin resistance [1] . Recently, there has been increasing interest in the association between ABO blood group and risk of IHD.
The antigens of the ABO system (A, B and H determinants, respectively) are inherited as Mendelian dominants. Their locus has been mapped to chromosome 9, and the molecular basis underlying polymorphism at this locus has been identified [2] . Indeed, earlier reports from the 1960-1970s have all suggested a (small but significant) higher risk of IHD in subjects of blood group A compared with other blood groups [3] . A recent report from the British Regional Heart Study also found a slightly higher incidence of IHD among individual subjects of blood group A but has suggested that the estimated relative risk was small and thus not likely to be clinically important [3] . In this current issue of the Journal of Cardiovascular Risk, Suadicani et al. [4] extend this relationship further by exploring the possibility of long-term occupational exposure to airborne occupational pollutants as an environmental risk factor for IHD, in relation to ABO blood group in over 3300 middle-aged and elderly men from the Copenhagen Male Study.
Their hypothesis may follow that different genotypes ('ABO phenotypes') could interact differently when exposed to an adverse environmental factor (in this case, 'exposure to airborne pollutants') and somehow influence disease susceptibility (that is, the 'risk' of IHD). Their data reveal that when exposed to longterm airborne pollutants, in particular soldering fumes, the lifetime prevalence of myocardial infarction (MI) was significantly higher in men with phenotype O than men with other phenotypes. However, when unexposed to airborne pollutants, men of blood group O actually had a lower risk of MI. Their 8-year follow-up also demonstrated a clear dose-relationship between years of occupational airborne pollutant exposure to the risk of suffering a first IHD event in subjects of O phenotype.
However, as pointed out by Suadicani et al. [4] , 'the question on which ABO phenotypes should be considered as high risk or low risk phenotypes cannot be answered unconditionally'. Indeed, the same authors reported more than a year ago [5] that socioeconomic status could be another such 'environmental factor' that influences the relation of ABO blood groups to the susceptibility to IHD. Indeed, men in social classes IV and V and with blood group O had an 80% higher risk of a first IHD event compared with those in social classes I, II, and III of the same blood group phenotype. In contrast, men with other blood group phenotypes and low social class had a risk of only 9%, which was not significantly increased.
Taking the two papers together, such data could imply that individuals with blood group O may have a lower risk of IHD (i.e. a 'protective phenotype') compared with other blood groups (which has repeatedly been reported by others [3] ) in the absence of an adverse environmental factor. However, blood group O individuals become more susceptible to the development of IHD when exposed to certain environmental factors, such as airborne occupational pollutants. Intriguingly, such relationships seems to be unaffected by other major cardiovascular (CV) risk factors such as smoking, diabetes mellitus or dyslipidaemia which appear to have a greater impact on men with blood group phenotype other than group O.
It is of note that environmental effects are most clearly shown between populations rather than between individuals, presumably because the differences are larger and/or more numerous [6] . The higher risk of IHD in O phenotypes who are also exposed to airborne pollutants [4] may therefore partly explain the observation by Mitchell in 1977 that towns with higher prevalence of blood group O had higher rates of CV mortality [7] . This observation was later confirmed in the British Regional Heart Study where blood group O was related to the incidence of IHD events on a town basis, whereas blood group A was related to the incidence of IHD at the individual level [3] . It is nevertheless possible that towns with a higher prevalence of blood group O also have a higher prevalence of habitants with lower social classes and/ or higher airborne pollutants and, thus, higher expression of IHD associated with blood group O phenotypes.
The entangled web of complex and multiple geneenvironment interactions may be important in facilitating development of new preventive or treatment strategies. For example specific environmental 'manipulation' could be directed at those especially susceptible to certain risk factors. In this case, subjects with blood group O and in lower social classes and/or exposed to air pollutants could be considered at higher risk of IHD and thus more 'aggressive' population preventive measures could be adopted, such as [sic] avoiding occupational exposure to airborne pollutants. Is 'Big Brother' watching us (or our genes, at least) and directing how or where we should live and work? Indeed, the extrapolation of results obtained in one population to another may not be valid and, thus, a deeper understanding of the underlying biological plausibility of such complex relationships between ABO phenotypes and risk of IHD, and the influence by external factors is necessary. It is difficult to be certain, and sometimes being too certain can be a dangerous thing.
Perhaps we should consider whether the epidemiological link is biologically plausible. The A, B and H determinants of blood groups actually consist of complex carbohydrate molecules that not only are expressed on red blood cells but also on a wide variety of human tissues, including platelets and the vascular endothelium, sensory neurones and epithelium [8] . Thus, the ABH antigens are not merely blood group classifying molecules with no other function. In fact, they have been associated with susceptibility to various infections, including Pseudomonas (group A), Helicobacter pylori (group O) and Salmonella typhii (group B). In addition, group A subjects not only have higher risk for IHD, but an increased incidence of many cancers, including rectal, cervical, gastric, breast and ovarian cancers [9] .
Perhaps the increased susceptibility to IHD may be explained by a prothrombotic state. For example, plasma levels of procoagulant molecules, von Willebrand factor (vWf, also an index of endothelial damage/dysfunction) and factor VIII (FVIII) are greatly affected by ABO groups; indeed, non-O individuals have significantly (approximately 25%) higher plasma levels of both molecules than group O individuals [10] [11] [12] . Indeed, increased vWf levels and ABO blood groups are independent risk factors for IHD [13, 14] , with the excess risk of IHD associated with group A individuals being attributable, at least in part, to their increased levels of the plasma vWf and/or FVIII [2] . Interestingly, both plasma-derived vWf and FVIII have N-linked oligosaccharide chains of ABH antigenic determinants on them according to blood group.
However, it remains unclear whether these carbohydrate complexes have any functional mediating effects between ABO blood group and plasma vWf and FVIII levels [2] . For example, individuals with genotype OO (group O) have the lowest vWf:Ag and FVIII:C levels; O allele heterozygous (genotypes AO and BO) have intermediate vWf:Ag and FVIII:C levels; whilst individuals not carrying the O allele (genotypes AA, AB or BB) have the highest levels [2, 15] . In studies of monozygotic and dizygotic twin pairs, about two-thirds of the total variation in both plasma vWf and FVIII antigen levels are genetically determined -30% and 12% respectively, of this genetic component is attributable to the ABO blood group. Linkage analysis studies have also shown that the ABO effect could be mediated through a direct functional effect of the ABO gene locus on plasma vWf levels, rather than linkagedisequilibrium between the ABO locus and another unknown vWf regulatory locus [2] .
Interestingly, vWf is not the only endothelial specific molecule that can be influenced by ABO blood group. For example, plasma levels of E-selectin (also an endothelial specific product) are lower in group A than in group O, and levels in group AB are also lower than in group O. Thrombomodulin, another endothelial specific product, is lower in groups O and A subjects than in those with group B. Other soluble adhesion molecules ICAM-1, VCAM-1 and P-selectin were also measured but were not significantly associated with ABO blood group [15] .
As suggested by the British Regional Heart Study, the estimated relative increase risk of IHD in blood group A middle aged British men is small (RR 1.21, 95% confidence interval [CI] 1.01-1.46) and is probably not clinically important. In subjects of blood group O, the relative risk of IHD was only 0.82 (95% CI 0.68-0.99) [3] . By contrast, in the studies by Suadicani et al. [4, 5] , the magnitude of these genotype effects markedly change with different environmental exposures, indicating that they are likely to be of some biological significance in causing an elevated risk of IHD in the presence of external adverse factors. What is more intriguing is the fact that such elevated risk was much stronger in group O subjects exposed to airborne pollutants (or with lower social classes) and was much less influenced by the traditional CV risk factors such as smoking than in other blood groups. Among men with blood group other than group O, the modest increased risk was attributable mainly to these common CV risk factors but very little to airborne pollutants or social classes [4, 5] .
Lower social classes are more commonly exposed to occupational airborne pollutants and vice versa. Furthermore, air pollution or occupational exposure to inhaled particles and low social classes are known risk factors for CV disease [16] . If, for some unknown reason, the prevalence of O phenotype is higher among the lower social classes (an assumption), then it is plausible that the elevated risk of IHD reported in blood group O phenotype may have no direct biological link with ABO blood group/genotypes (that is, a pure covariant with no significant biological function), rather it is due to a link to social classes or occupational exposure to particles.
Indeed, Seaton et al. have hypothesized that acidic ultrafine particles characteristic of urban air pollution can provoke alveolar inflammation with acute release of interleukin-6 from macrophages and thus induce changes in blood coagulation factors including fibrinogen and tissue factor, especially in those most susceptible, the elderly [16]. However, it can also be hypothesized that the acute inflammation induced by airborne particles somehow triggers a biological pathway that is related to blood O genotype only and different from one that is triggered by smoking, which seems related to other nongroup O genotypes.
The biological complexity of CV disease results from unknown or unpredictable interactions of many genetic and environmental factors which, by themselves, have only been partially identified. Indeed, airborne occupational exposure and ABO phenotype is yet another example of gene-environment interaction in the complex multifactorial nature of the pathogenesis of IHD.
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